moxifloxacin has been researched along with ebastine in 3 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (ebastine) | Trials (ebastine) | Recent Studies (post-2010) (ebastine) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 237 | 75 | 58 |
| Protein | Taxonomy | moxifloxacin (IC50) | ebastine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 4 | Cavia porcellus (domestic guinea pig) | 0.2375 | |
| Epidermal growth factor receptor | Homo sapiens (human) | 0.5591 | |
| Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 1.0575 | |
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 0.8101 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 0.4603 | |
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.786 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.8279 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 1.5 | |
| 5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.047 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.3378 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 0.8316 | |
| Adenosine receptor A3 | Homo sapiens (human) | 3.1953 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 0.92 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.8734 | |
| Angiotensin-converting enzyme | Oryctolagus cuniculus (rabbit) | 0.1048 | |
| Beta-3 adrenergic receptor | Homo sapiens (human) | 2.5455 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.605 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 1.1871 | |
| Alpha-2B adrenergic receptor | Homo sapiens (human) | 0.7389 | |
| Alpha-2C adrenergic receptor | Homo sapiens (human) | 0.2757 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.6475 | |
| Substance-K receptor | Homo sapiens (human) | 1.9329 | |
| D(1A) dopamine receptor | Homo sapiens (human) | 1.1929 | |
| D(4) dopamine receptor | Homo sapiens (human) | 1.2996 | |
| Acetylcholinesterase | Homo sapiens (human) | 7.4799 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.183 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.4603 | |
| Histamine H2 receptor | Homo sapiens (human) | 2.9157 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.9771 | |
| 5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 0.0904 | |
| 5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 0.2375 | |
| Adenosine receptor A2a | Rattus norvegicus (Norway rat) | 0.047 | |
| Histamine H1 receptor | Cavia porcellus (domestic guinea pig) | 0.045 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 1.2287 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.183 | |
| Histamine H1 receptor | Homo sapiens (human) | 0.0283 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.183 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.1216 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 0.3126 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 1.1871 | |
| 5-hydroxytryptamine receptor 6 | Homo sapiens (human) | 2.1974 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.0987 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 1.152 | |
| 5-hydroxytryptamine receptor 4 | Homo sapiens (human) | 0.061 | |
| Nuclear receptor subfamily 3 group C member 3 | Bos taurus (cattle) | 0.1048 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagashima, R; Nishikawa, T; Tobita, M | 1 |
| Sen, S; Sinha, N | 1 |
| Alemán, AM; Cuesta, J; Novalbos, A; Quirce, S; Sastre, J | 1 |
3 other study(ies) available for moxifloxacin and ebastine
| Article | Year |
|---|---|
A discriminant model constructed by the support vector machine method for HERG potassium channel inhibitors.
Topics: Animals; CHO Cells; Cricetinae; Discriminant Analysis; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Potassium Channel Blockers; Potassium Channels, Voltage-Gated | 2005 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Anaphylactoid reaction caused by moxifloxacin.
Topics: Adult; Anaphylaxis; Anti-Infective Agents; Aza Compounds; Butyrophenones; Female; Fluoroquinolones; Humans; Moxifloxacin; Otitis; Piperidines; Quinolines | 2002 |